Lipids and Lipid Disorders

Contributing journals to this collection:
JAMA & Archives Journals

Citations 381-390 of 550 total displayed.

Past content

Commentaries
The New National Cholesterol Education Program Guidelines: Clinical Challenges for More Widespread Therapy of Lipids to Treat and Prevent Coronary Heart Disease

Rachel S. Eidelman; Gervasio A. Lamas; Charles H. Hennekens
Arch Intern Med 2002; 162: 2033-2036. [Extract] [Full text] [PDF]  

Original Investigations
Body Mass Index, Waist Circumference, and Health Risk: Evidence in Support of Current National Institutes of Health Guidelines

Ian Janssen; Peter T. Katzmarzyk; Robert Ross
Arch Intern Med 2002; 162: 2074-2079. [Abstract] [Full text] [PDF]  

Original Articles
A Dose-Ranging Study of the Effects of Ethyl-Eicosapentaenoate in Patients With Ongoing Depression Despite Apparently Adequate Treatment With Standard Drugs

Malcolm Peet; David F. Horrobin
Arch Gen Psychiatry 2002; 59: 913-919. [Abstract] [Full text] [PDF]  

Scientific Review and Clinical Applications
New Evidence for Stroke Prevention: Scientific Review

Sharon E. Straus; Sumit R. Majumdar; Finlay A. McAlister
JAMA 2002; 288: 1388-1395. [Abstract] [Full text] [PDF]  

Original Investigations
Efficacy, Safety, and Tolerability of Once-Daily Niacin for the Treatment of Dyslipidemia Associated With Type 2 Diabetes: Results of the Assessment of Diabetes Control and Evaluation of the Efficacy of Niaspan Trial

Scott M. Grundy; Gloria Lena Vega; Mark E. McGovern; Brian R. Tulloch; David M. Kendall; David Fitz-Patrick; Om P. Ganda; Robert S. Rosenson; John B. Buse; David D. Robertson; John P. Sheehan; for the Diabetes Multicenter Research Group
Arch Intern Med 2002; 162: 1568-1576. [Abstract] [Full text] [PDF]  

Original Articles
Cholesterol and Serum Albumin Levels as Predictors of Cross Infection, Death, and Length of Hospital Stay

Miguel Delgado-Rodríguez; Marcelino Medina-Cuadros; Antonio Gómez-Ortega; Gabriel Martínez-Gallego; Marcial Mariscal-Ortiz; Miguel Angel Martinez-Gonzalez; María Sillero-Arenas
Arch Surg 2002; 137: 805-812. [Abstract] [Full text] [PDF]  

Editorials
Statin Therapy in Older Persons: Pertinent Issues

Scott M. Grundy
Arch Intern Med 2002; 162: 1329-1331. [Extract] [Full text] [PDF]  

Original Investigations
Therapy With Hydroxymethylglutaryl Coenzyme A Reductase Inhibitors (Statins) and Associated Risk of Incident Cardiovascular Events in Older Adults: Evidence From the Cardiovascular Health Study

Rozenn N. Lemaitre; Bruce M. Psaty; Susan R. Heckbert; Richard A. Kronmal; Anne B. Newman; Gregory L. Burke
Arch Intern Med 2002; 162: 1395-1400. [Abstract] [Full text] [PDF]  

Editorials
Estimating Treatment Effects From Observational Data: Dissonant and Resonant Notes From the SYMPHONY Trials

Karin B. Michels; Eugene Braunwald
JAMA 2002; 287: 3130-3132. [Extract] [Full text] [PDF]  

Original Investigations
A Randomized Trial of the Effect of Community Pharmacist Intervention on Cholesterol Risk Management: The Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP)

Ross T. Tsuyuki; Jeffrey A. Johnson; Koon K. Teo; Scot H. Simpson; Margaret L. Ackman; Rosemarie S. Biggs; Andrew Cave; Wei-Ching Chang; Vladimir Dzavik; Karen B. Farris; Donna Galvin; William Semchuk; Jeff G. Taylor; for the Study of Cardiovascular Risk Intervention by Pharmacists Investigators
Arch Intern Med 2002; 162: 1149-1155. [Abstract] [Full text] [PDF]  

[First page]   [Previous page]   [Next page] Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55